slides · global inventory
Roadmap
Slide type collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 3,235
Current window 1,861-1,890
Pages 108
Rows per page 30
Slide type
1,861-1,890 of 3,235
05
The slide uses a Gantt-style visualization to show drug development stages.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
18
The slide outlines two parallel study arms with randomization at week 24.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations 1 hit
09
The slide uses a 3D-like coordinate system to show expansion vectors.argenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · WhatLoop · Cost Of Inaction1 hit
14
The slide uses a split-screen layout: left side details the mechanism of action and current status of the MMN study, right side details the future roadmap.argenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · The GoalLoop · Quick Win Big Bet1 hit
15
Includes a biological mechanism diagram on the left and a clinical trial roadmap on the right.argenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · The GoalLoop · Quick Win Big Bet1 hit
20
The chart uses a horizontal bar format to represent clinical trial phases (Preclinical to Commercial) for multiple indications under four main programs.argenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · Visualization1 hit
07
The slide uses a timeline-based progression (2023 -> Proof of Value -> Platform Innovation) mapped against product generations.Benson Hill | Results Presentation Deck | 30 slides · Benson Hill
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
08
The slide uses a timeline-based process flow to illustrate the strategic progression.Benson Hill | Results Presentation Deck | 30 slides · Benson Hill
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
17
The slide uses a visual progression path (stepping stones) to show the journey from current state to future target.Essity | Results Presentation Deck | 19 slides · Essity
Conference presentation Investor relations Beat · Road to ROCE Target1 hit
04
Exscientia | Investor Presentation Deck | 73 slidesExscientia | Investor Presentation Deck | 73 slides · Exscientia
Pitch deck Investor relations 1 hit
07
The chart uses a horizontal bar format to represent development stages.Exscientia | Investor Presentation Deck | 73 slides · Exscientia
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
10
The slide uses a stepped arrow diagram to represent progress over time, categorized into three phases of target difficulty.Exscientia | Investor Presentation Deck | 73 slides · Exscientia
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
30
The slide outlines a standard oncology clinical trial design (Phase 1/2) with a specific focus on biomarker-driven patient selection.Exscientia | Investor Presentation Deck | 73 slides · Exscientia
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
37
The slide outlines a standard oncology clinical trial design (Phase 1/2) with a transition point at RP2D (Recommended Phase 2 Dose).Exscientia | Investor Presentation Deck | 73 slides · Exscientia
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
05
The slide uses a Gantt-style visualization to map drug development progress against clinical phases.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Beat · Problem1 hit
18
The slide outlines a randomized, open-label trial comparing Olvi-Vec + Platinum-doublet + Bevacizumab against a standard comparator arm.Genelux | Investor Presentation Deck | 38 slides · Genelux
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
05
The slide uses a Gantt-style visual for the 'Pre-clinical' stage, though it is not a full timeline.Hillstream BioPharma | Investor Presentation Deck | 19 slides · Hillstream BioPharma
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
14
The slide uses a timeline-based growth framework to show the transition from ICE to BEV models.Lotus Cars | SPAC Presentation Deck | 60 slides · Lotus
Pitch deck Investment bank 1 hit
15
Includes a vertical arrow annotation indicating the transition to BEV models after 2022.Lotus Cars | SPAC Presentation Deck | 60 slides · Lotus
Pitch deck Investment bank 1 hit
25
The slide uses a timeline framework to demonstrate competitive advantage in market entry timing.Lotus Cars | SPAC Presentation Deck | 60 slides · Lotus
Pitch deck Investment bank 1 hit
05
The slide uses a Gantt-style visualization to track drug development progress.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
21
The slide outlines a clinical trial design using a basket/umbrella approach to test THIO in combination with various anti-PD-1/PD-L1 therapies.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
27
The slide outlines a clinical development pathway involving immune activation and combination therapies.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
34
The slide uses a timeline format with star icons to denote major inflection points.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
29
The slide uses a funnel-like diagram to show how four strategic pillars feed into a unified vision.Nano Dimension | Mergers and Acquisitions Presentation Deck | 36 slides · Nano Dimension
Activist deck Investment bank 1 hit
05
The slide uses a timeline-style layout to represent drug development stages.Nuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · Problem1 hit
12
The slide uses a split-column layout to contrast the completed Phase 1a with the active Phase 1b.Nuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · Market Size1 hit
20
Clinical trial identifier NCT05873686 is provided.Nuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
45
Uses a three-column temporal framework to organize business initiatives.Snap Inc | Investor Presentation Deck | 50 slides · Snap Inc.
Pitch deck Investor relations 1 hit
29
The slide uses a grid of five callout boxes to present strategic initiatives.VinFast | Investor Presentation Deck | 29 slides · VinFast
Pitch deck Investor relations 1 hit